Cat
Name
Size
Price
Action
BNC403350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF640R conjugate
100 µL
Ask
BNC473350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF647 conjugate
500 µL
Ask
BNC403348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF640R conjugate
500 µL
Ask
BNCB3347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), Biotin conjugate
500 µL
Ask
BNC742836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF740 conjugate
100 µL
Ask
BNUB3348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
500 µL
Ask
BNUM3348-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
50 µL
Ask
BNUB3350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
100 µL
Ask
BNC043347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF405S conjugate
100 µL
Ask
BNC943348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF594 conjugate
500 µL
Ask
BNC403347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF640R conjugate
500 µL
Ask
BNUB2836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
500 µL
Ask
BNC883347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF488A conjugate
100 µL
Ask
BNC473350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF647 conjugate
100 µL
Ask
PA484a
Pancreas adenocarcinoma with pancreas tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores ( core size2.0mm), replacing PA484-PA484a
each
Ask
PA1003
Pancreatic ductal adenocarcinoma (PDAC) tissue array for antibody screening, including TNM and pathology grade (WHO 2010 Edition), 25 cases/100 cores-PA1003
each
Ask
BNUB3348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348)
100 µL
Ask
BNC943347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF594 conjugate
500 µL
Ask
BNC943347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF594 conjugate
100 µL
Ask
BNC882836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF488A conjugate
100 µL
Ask
BNCB3347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), Biotin conjugate
100 µL
Ask
BNC883350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF488A conjugate
500 µL
Ask
BNC402836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF640R conjugate
100 µL
Ask
BNUB3350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350)
500 µL
Ask
BNC042576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF405S conjugate
100 µL
Ask
BNUB2576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
100 µL
Ask
BNC402576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF640R conjugate
500 µL
Ask
BNC472576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF647 conjugate
500 µL
Ask
BNC682576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF568 conjugate
100 µL
Ask
BNC683347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF568 conjugate
100 µL
Ask
BNC472836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF647 conjugate
100 µL
Ask
BNC943350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF594 conjugate
500 µL
Ask
BNC743350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF740 conjugate
100 µL
Ask
BNUM2576-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576)
50 µL
Ask
BNC472576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF647 conjugate
100 µL
Ask
BNC743347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF740 conjugate
100 µL
Ask
BNC043350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF405S conjugate
500 µL
Ask
BNC473347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF647 conjugate
100 µL
Ask
BNC682836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF568 conjugate
100 µL
Ask
BNUB3347-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347)
100 µL
Ask
MBS4382112-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Recombinant Mouse Monoclonal Antibody [Clone rNKX3.1/6620]
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4382112-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Recombinant Mouse Monoclonal Antibody [Clone rNKX3.1/6620]
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4382112-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Recombinant Mouse Monoclonal Antibody [Clone rNKX3.1/6620]
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4382112-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Recombinant Mouse Monoclonal Antibody [Clone rNKX3.1/6620]
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4382112-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Recombinant Mouse Monoclonal Antibody [Clone rNKX3.1/6620]
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381116-01
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-02
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-03
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS4381116-04
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS4381116-05
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
BNC472836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF647 conjugate
500 µL
Ask
BNC943348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF594 conjugate
100 µL
Ask
BNC042836-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF405S conjugate
100 µL
Ask
BNC742836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF740 conjugate
500 µL
Ask
BNC743348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF740 conjugate
100 µL
Ask
BNC743350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF740 conjugate
500 µL
Ask
BNC683348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF568 conjugate
500 µL
Ask
BNC942576-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF594 conjugate
100 µL
Ask
BNC043348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF405S conjugate
500 µL
Ask
BNC743347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF740 conjugate
500 µL
Ask
BNUM3347-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347)
50 µL
Ask
BNUM2836-50
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836)
50 µL
Ask
BNCB3348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), Biotin conjugate
100 µL
Ask
BNC043350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF405S conjugate
100 µL
Ask
BNC473348-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF647 conjugate
500 µL
Ask
BNC403348-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3348), CF640R conjugate
100 µL
Ask
BNC683347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF568 conjugate
500 µL
Ask
BNCB3350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), Biotin conjugate
100 µL
Ask
BNC042576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF405S conjugate
500 µL
Ask
BNC683350-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF568 conjugate
500 µL
Ask
BNC683350-100
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3350), CF568 conjugate
100 µL
Ask
BNC402836-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2836), CF640R conjugate
500 µL
Ask
BNC473347-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/3347), CF647 conjugate
500 µL
Ask
BNC682576-500
Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker)(NKX3.1/2576), CF568 conjugate
500 µL
Ask
CO243c
Colon adenocarcinoma tissue array with matched NAT tissue as control, including pathology grade, TNM and clinical stage, 9 cases/24 cores (core size 1.5mm), replacing CO243b-CO243c
each
Ask
CO722
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021-CO722
each
Ask
T191b
Prostate adenocarcinoma test tissue array, with prostate control tissues, pathology grade, TNM and clinical stage (AJCC 8.0), 6 cases/24 cores, replacing T191a (1.5mm)-T191b
each
Ask
ST8014a
Stomach adenocarcinoma with stomach tissue array, including pathology grade, TNM and clinical stage (AJCC 7th edition), 80 cases/80 cores (core size 1.5mm), replacing ST8014-ST8014a
each
Ask
LC10013c
Lung adenocarcinoma with matched adjacent normal lung tissue array, including pathology grade, TNM and clinical stage, 52 cases/100 cores, replacing LC10013b-LC10013c
each
Ask
SM1501
Small intestine ( most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores-SM1501
each
Ask
GI1701
Colon adenocarcinoma and rectum adenocarcinoma tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 85 cases/170 cores (1.0mm), replacing BC000110-GI1701
each
Ask
PA482a
Pancreas ductal adenocarcinoma (PDAC) with pancreas tissue array, including pathology grade, TNM/Stage (AJCC 8th edition), 24 cases/48 cores (core size 1.5mm), replacing PA482-PA482a
each
Ask
PA601
Pancreas adenocarcinoma with matched adjacent normal or cancer adjacent pancreas tissue array, including pathology, TNM and clinical stage (reference AJCC 8th version), 37 cases/60 cores-PA601
each
Ask
LC1531
Lung adenocarcinoma with matched normal adjacent or cancer adjacent lung tissue array, including pathology grade, TNM/Stage (AJCC 8th edition), 51 cases/153 cores (core size 1.0mm), replacing LC1504-LC1531
each
Ask
CO953a
Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953-CO953a
each
Ask
REF482
Rectum adenocarcinoma with normal and adjacent rectum tissues, recent years collection, including pathology grade, TNM and clinical stage ( AJCC 8th Edition), 45 cases/48 cores, replacing RE482-REF482
each
Ask
PA721a
Pancreatic cancer tissue array with normal pancreatic tissue, including duct adenocarcinoma ( PADC) and islet cell carcinoma, TNM and pathology grade, 24 cases/96 cores ( core size 1.5mm), replacing PA721-PA721a
each
Ask
LC992a
Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/99 cores, replacing LC992-LC992a
each
Ask
PA2082a
Pancreas cancer with pancreas tissue array, including ductal adenocarcinoma ( PADC) , acinar cell carcinoma ( PACC) , normal adjacent and pancreas tissue, pathology grade, TNM and clinical stage, 96 cases/192 cores ( 1.0mm), replacing PA2082-PA2082a
each
Ask
OV1021
Ovary tumor array with normal tissue , including cystadenocarcinoma, endometrioid adenocarcinoma, clear cell cacinoma and cystadenoma , with pathology grade, TNM/Stage (AJCC 8th edition), 102 cases/102 cores (core size 1.5mm)-OV1021
each
Ask
PA807
Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including duct adenocarcinoma ( PADC), cancer adjaceent pancreatic and normal tissue TNM, clinical stage and pathology grade, 80 cases/ 80 cores ( 1.5mm)-PA807
each
Ask
LC641b
Lung adenocarcinom tissue array, including invasive papillary adenocarcinoma, invasive mucinous adenocarcinoma and invasive adenocarcinoma, pathology grade, TNM and clinical stage, 64 cases/64 cores (core size 1.5mm), replacing LC641a-LC641b
each
Ask
ES1041
Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma, adenocarcinoma, undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm) , replacing ES1021-ES1041
each
Ask
PA805c
Pancreas cancer with pancreas tissue array, including duct adenocarcinoma ( PDAC), acinar cell carcinoma ( PACC) , squamous cell carcinoma, normal adjacent pancreas and normal tissuepathology grade, TNM and clinical stage, 80 cases/80 cores ( 1.5mm), replacing PA805b-PA805c
each
Ask
UT802a
Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802-UT802a
each
Ask
PA242f
Pancreas adenocarcinoma with cancer adjacent tissue array, including ductal adenocarcinoma, papillary adenocarcinoma, mucinous adenocarcinoma and cancer adjacent pancreas tissue, pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores (core size 1.5mm), replacing PA242e-PA242f
each
Ask
TP242f
Top 4 types of cancer (colon, breast, lung and prosate) with normal tissue array, including colon adenocarcinoma, breast invasive carcinoma of no special type, prostate adenocarcinoma, lung squamous cell carcinoma, lung adenocarcinoma, grade, TNM and clinical state (AJCC 8.0), 24 cases/24 cores (core size 1.5mm), replacing TP242e, Recent Year Collection-TP242f
each
Ask
OV901
Multiple ovary tumor with matched cancer adjacent ovary tissue array, including serous carcinoma, clear cell carcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, disgerminoma, yolk sac tumor and sertoli-Leydig cell tumors and mixed germ cell tumor, thology grade, TNM and clinical stage (AJCC 8.0), 76 cases/90 cores (1.5mm)-OV901
each
Ask